Document Detail


Scheduling of anticancer drugs: timing may be everything.
MedLine Citation:
PMID:  23032365     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Many cancer patients are treated with a combination of anticancer drugs. Here, we discuss the importance of drug scheduling and the need for studies that investigate the optimal timing of the various anticancer drugs. Positron emission tomography (PET) using radiolabeled anticancer drugs could be an important tool for those studies.
Authors:
Astrid A M Van der Veldt; Adriaan A Lammertsma; Egbert F Smit
Related Documents :
23121385 - Ultrasound-enhanced drug delivery for cancer.
24300405 - Exploring polymeric micelles for improved delivery of anticancer agents: recent develop...
24456605 - Dynamic disordering of liposomal cocktails and the spatio-temporal favorable release of...
2616585 - A conjugate of prednisolone with albumin is pharmacologically active in macrophages.
8748045 - First clinical experience with olanzapine (ly 170053): results of an open-label safety ...
15798895 - The chemistry and biology of inhibitors and pro-drugs targeted to glutathione s-transfe...
Publication Detail:
Type:  Journal Article     Date:  2012-10-03
Journal Detail:
Title:  Cell cycle (Georgetown, Tex.)     Volume:  11     ISSN:  1551-4005     ISO Abbreviation:  Cell Cycle     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  2013-05-17     Revised Date:  2013-12-04    
Medline Journal Info:
Nlm Unique ID:  101137841     Medline TA:  Cell Cycle     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4339-43     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / administration & dosage*,  chemistry,  diagnostic use
Drug Administration Schedule
Humans
Isotope Labeling
Neoplasms / diagnosis,  drug therapy*
Positron-Emission Tomography
Radiopharmaceuticals / administration & dosage*,  chemistry,  diagnostic use
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Radiopharmaceuticals
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Interaction of oxygen vacancies in yttrium germanates.
Next Document:  PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.